Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2005;106:1204-1206
© 2005 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nabatian, S.
Right arrow Articles by Lakier, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nabatian, S.
Right arrow Articles by Lakier, J.
Related Collections
Right arrow Hypertension and PIH
Right arrow Medical complications of pregnancy

CASE REPORTS

Acute Coronary Syndrome and Preeclampsia

Sepideh Nabatian, MD1, Patrick Quinn, DO1, Leslie Brookfield, MD1 and Jeffrey Lakier, MD1

From the 1Department of Cardiology, Lutheran General Hospital, Park Ridge, Illinois.

BACKGROUND: Myocardial ischemia and infarction are rare during pregnancy. Approximately 150 cases of myocardial infarction during pregnancy have been documented in the literature worldwide (predominantly anterior wall). However, elevated troponin levels have been reported in patients with preeclampsia.

CASES: We describe 2 patients with preeclampsia who presented with acute myocardial ischemia; 1 with ST segment elevation and one non-ST segment elevation at EKG. Our patients clearly had acute coronary syndromes with troponin levels much higher than would be accounted for by preeclampsia.

CONCLUSIONS: From the existing body of literature regarding this patient population, it is unclear why there is a higher incidence of adverse myocardial events. It may be that coronary ischemia has been missed in patients with preeclampsia. Troponin I is now readily available for detection of myocardial damage and should be used in this patient population only when clinically indicated, such as when chest discomfort or new electrocardiogram changes are observed. Patients with preeclampsia may be at higher risk for coronary events, and troponin I levels could be a valuable tool with which to monitor women who develop related symptoms.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Obstetricians and Gynecologists.